Case report: Multiple brain tuberculomas after fertilization, embryo transfer, and abortion.

Zhaobo Shi, Yong Sun
Author Information
  1. Zhaobo Shi: Neurology Department, Kaingfeng Central Hospital, Kaifeng, China.
  2. Yong Sun: Neurology Department, Kaingfeng Central Hospital, Kaifeng, China.

Abstract

Background: Multiple brain tuberculomas (MBT), characterized by disseminated tuberculous granulomas in the brain, is a rare disease like tuberculosis encountered after fertilization, embryo transfer (IVF-ET), and abortion. This study aimed to investigate the clinical characteristics, diagnostic methods, and therapeutic strategies of MBT after IVF-ET and abortion.
Methods: A retrospective analysis was performed on the data of two patients who suffered from MBT after IVF-ET and abortion.
Results: Both patients manifested headache and vomiting, which are the common symptoms of intracranial hypertension, accompanied by tuberculous meningitis. Besides, case 1 was affected by fever and epilepsy. In terms of imaging characteristics, T2-weighted imaging (T2WI) displayed multiple intracranial punctate or patchy high-intensity signals, some of which were presented as "target sign" or enhanced-like disseminated nodules, similar to miliary tuberculosis. Regular anti-tuberculosis therapy with isoniazid, rifampicin, pyrazinamide, and ethambutol was administered but failed to achieve a significant effect in the initial stage. The symptoms were gradually relieved, and the brain lesions in MRI were significantly alleviated after combining with intrathecal injections of isoniazid, dexamethasone, and chymotrypsin.
Conclusions: fertilization, embryo transfer (IVF-ET) may be a risk factor for MBT, the common manifestations of which are intracranial hypertension. In addition to multiple nodular enhancement on brain MRI, the "target sign" on T2WI is likely to be another typical feature of MBT. Provided that there is no obvious effect of regular anti-tuberculosis therapy (ATT), intrathecal injections of isoniazid, dexamethasone, and chymotrypsin are considered to produce a favorable prognosis, but further studies are still needed to confirm the efficacy.

Keywords

References

  1. Clin Infect Dis. 2012 Dec;55(11):1532-49 [PMID: 22942202]
  2. J Neuroimaging. 2019 Sep;29(5):657-668 [PMID: 31115112]
  3. Infect Dis Rep. 2021 Mar 01;13(1):181-186 [PMID: 33804334]
  4. Int J Tuberc Lung Dis. 2007 Jan;11(1):91-5 [PMID: 17217136]
  5. J Neurol Sci. 2017 Oct 15;381:256-264 [PMID: 28991694]
  6. J Emerg Med. 2010 Apr;38(3):323-7 [PMID: 18439780]
  7. Microbiol Spectr. 2017 Mar;5(2): [PMID: 28281443]
  8. Int J Gynaecol Obstet. 2012 Apr;117(1):40-4 [PMID: 22265187]
  9. World Neurosurg. 2019 May;125:e236-e247 [PMID: 30684718]
  10. Ann Med. 2022 Dec;54(1):71-79 [PMID: 34955089]
  11. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:108-115 [PMID: 28011331]
  12. N Engl J Med. 2011 Oct 20;365(16):1527 [PMID: 22010919]
  13. Zhonghua Jie He He Hu Xi Za Zhi. 2015 Nov;38(11):821-7 [PMID: 26850770]
  14. Brain Pathol. 2018 Mar;28(2):303-305 [PMID: 29516658]
  15. Jpn J Infect Dis. 2016 May 20;69(3):231-5 [PMID: 26255731]

Word Cloud

Created with Highcharts 10.0.0brainMBTfertilizationembryotransferIVF-ETabortiontuberculousintracranialmultipleanti-tuberculosistherapyisoniazidintrathecalMultipletuberculomasdisseminatedtuberculosischaracteristicspatientscommonsymptomshypertensionmeningitisimagingT2WI"targetsign"effectMRIinjectionsdexamethasonechymotrypsinBackground:characterizedgranulomasrarediseaselikeencounteredstudyaimedinvestigateclinicaldiagnosticmethodstherapeuticstrategiesMethods:retrospectiveanalysisperformeddatatwosufferedResults:manifestedheadachevomitingaccompaniedBesidescase1affectedfeverepilepsytermsT2-weighteddisplayedpunctatepatchyhigh-intensitysignalspresentedenhanced-likenodulessimilarmiliaryRegularrifampicinpyrazinamideethambutoladministeredfailedachievesignificantinitialstagegraduallyrelievedlesionssignificantlyalleviatedcombiningConclusions:mayriskfactormanifestationsadditionnodularenhancementlikelyanothertypicalfeatureProvidedobviousregularATTconsideredproducefavorableprognosisstudiesstillneededconfirmefficacyCasereport:vitroinjectiontuberculoma

Similar Articles

Cited By